Summary statement: Novel agents in the treatment of lung cancer: Advances in epidermal growth factor receptor-targeted agents

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Tim G. Eisen, Jeffrey Engelman, Glenwood D. Goss, Daniel A. Haber, John V. Heymach, Pasi A. Jänne, Bruce E. Johnson, David H. Johnson, Rogerio C. Lilenbaum, Matthew Meyerson, Alan B. Sandler, Lecia V. Sequist, Jeffrey Settleman, Kwok Kin Wong, Carol S. Hart

Research output: Contribution to journalArticle

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)4365s-4371s
JournalClinical Cancer Research
Volume12
Issue number14
DOIs
StatePublished - Jul 15 2006

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lynch, T. J., Adjei, A. A., Bunn, P. A., Eisen, T. G., Engelman, J., Goss, G. D., Haber, D. A., Heymach, J. V., Jänne, P. A., Johnson, B. E., Johnson, D. H., Lilenbaum, R. C., Meyerson, M., Sandler, A. B., Sequist, L. V., Settleman, J., Wong, K. K., & Hart, C. S. (2006). Summary statement: Novel agents in the treatment of lung cancer: Advances in epidermal growth factor receptor-targeted agents. Clinical Cancer Research, 12(14), 4365s-4371s. https://doi.org/10.1158/1078-0432.CCR-06-1005